Liens utiles

Institut National du Cancer agence d'expertise sanitaire et scientifique en cancérologie

Nota Bene Cancer bulletin de veille bibliographique dans les divers domaines de la recherche sur les cancers

Onco Actu brèves sur le web anglophone

 

Tous les liens utiles

Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2016

How to report toxicity associated with targeted therapies?

Cabarrou B et al., Ann Oncol. 2016 Aug;27(8):1633-8.

2016

Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.

Blanchard P et al., Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):85-92.

2016

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

Carrie C et al., Lancet Oncol. 2016 Jun;17(6):747-56.

2016

GENESIS: A French national resource to study the missing heritability of breast cancer.

Sinilnikova OM et al., BMC Cancer (2016) 16:13

2016

Mutation screening of MIR146A/B and BRCA1/2 3'UTRs in the GENESIS study

Garcia AI et al., Eur J Hum Genet. 2016 Aug;24(9):1324-9.

2016

Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck?

Danesi R et al., Ann Oncol. 2016 Sep 29.

2016

Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations.

Fu Y et al., Cancer Res. 2016 Oct 15;76(20):5954-5961.

2015

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.

Bureau E et al, Health Expect. 2015 Dec;18(6):2425-36. doi: 10.1111/hex.12211. Epub 2014 May 30

2016

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.

Garcia AI et al., Eur J Hum Genet. 2016 Jan 20. doi: 10.1038/ejhg.2015.284

2015

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.

Bougeard G et al., J Clin Oncol. 2015 Jul 20;33(21):2345-52. doi: 10.1200/JCO.2014.59.5728. Epub 2015 May 26